Open App
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals & DrugsAnnouncement - Suven Pharma
Suven Pharma
BSE: 543064NSE: SUVENPHARISIN: INE03QK01018

23rd-Sep-2022 14:53Source: BSE

Suven Pharmaceuticals - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has received intimation from shareholder of the Company, regarding loss of share certificate(s) as details mentioned below. A copy of intimation from Shareholder is enclosed herewith.Name of the Holder Folio No. No. of Shares Certificate No.(s) Distinctive Nos. date of receipt of information From To GUMAN MAL JAIN SPC0164189 1000 164189 127242479 127243478 21/09/2022 1000 277064 254529957 254530956 The Company is in process of issuing 'Letter of Confirmation' in lieu of the original share certificate(s), after completion of required formalities.

Sections